These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 6502004

  • 1. Opsonic activity of immunoglobulin prepared for intravenous use.
    Hetherington SV, Giebink GS.
    J Lab Clin Med; 1984 Dec; 104(6):977-86. PubMed ID: 6502004
    [Abstract] [Full Text] [Related]

  • 2. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.
    Garbett ND, Munro CS, Cole PJ.
    Clin Exp Immunol; 1989 Apr; 76(1):8-12. PubMed ID: 2500275
    [Abstract] [Full Text] [Related]

  • 3. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J, Peterson P, Kim Y, Sabath LD, Quie PG.
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [Abstract] [Full Text] [Related]

  • 4. Decreased serum opsonic activity against Streptococcus pneumoniae in human immunodeficiency virus-infected Ugandan adults.
    Takahashi H, Oishi K, Yoshimine H, Kumatori A, Moji K, Watanabe K, Nalwoga H, Tugume SB, Kebba A, Mugerwa R, Mugyenyi P, Nagatake T.
    Clin Infect Dis; 2003 Dec 01; 37(11):1534-40. PubMed ID: 14614677
    [Abstract] [Full Text] [Related]

  • 5. Requirements for the opsonic activity of human IgG directed to type 6 group A streptococci: net basic charge and intact Fc region.
    Fischetti VA.
    J Immunol; 1983 Feb 01; 130(2):896-902. PubMed ID: 6336773
    [Abstract] [Full Text] [Related]

  • 6. Comparison of antibody activity against various microorganisms in intravenous immunoglobulin preparations determined by ELISA and opsonic assay.
    Hiemstra PS, Brands-Tajouiti J, van Furth R.
    J Lab Clin Med; 1994 Feb 01; 123(2):241-6. PubMed ID: 8301200
    [Abstract] [Full Text] [Related]

  • 7. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
    Giebink GS, Grebner JV, Kim Y, Quie PG.
    Yale J Biol Med; 1978 Feb 01; 51(5):527-38. PubMed ID: 34937
    [Abstract] [Full Text] [Related]

  • 8. Antibody inhibition of polymorphonuclear phagocytosis. Dissociation of bacterial attachment and bacterial killing.
    Crowley JP, Valeri CR.
    J Lab Clin Med; 1980 Jun 01; 95(6):868-76. PubMed ID: 7381296
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Opsonins in human serum for the phagocytosis of complexes between IgG and protein A of Staphylococcus aureus.
    Hällgren R, Stålenheim G.
    Immunology; 1978 Jul 01; 35(1):13-20. PubMed ID: 680797
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ovine opsonins for Staphylococcus aureus cell wall and pseudocapsule.
    Watson DL.
    Res Vet Sci; 1989 Jan 01; 46(1):84-9. PubMed ID: 2784216
    [Abstract] [Full Text] [Related]

  • 14. Opsonic activity of human IgG and IgM antibody for type III group B streptococci.
    Anthony BF, Concepcion NF.
    Pediatr Res; 1989 Oct 01; 26(4):383-7. PubMed ID: 2677951
    [Abstract] [Full Text] [Related]

  • 15. Phagocytosis by human alveolar macrophages and neutrophils: qualitative differences in the opsonic requirements for uptake of Staphylococcus aureus and Streptococcus pneumoniae in vitro.
    Hof DG, Repine JE, Peterson PK, Hoidal JR.
    Am Rev Respir Dis; 1980 Jan 01; 121(1):65-71. PubMed ID: 7352714
    [Abstract] [Full Text] [Related]

  • 16. Deficiencies in opsonic defense to pneumococci in the human newborn despite adequate levels of complement and specific IgG antibodies.
    Geelen SP, Fleer A, Bezemer AC, Gerards LJ, Rijkers GT, Verhoef J.
    Pediatr Res; 1990 May 01; 27(5):514-8. PubMed ID: 2345679
    [Abstract] [Full Text] [Related]

  • 17. Serum opsonic activity in rodent malaria: functional and immunochemical characteristics in vitro.
    Hunter KW, Winkelstein JA, Simpson TW.
    J Immunol; 1979 Dec 01; 123(6):2582-7. PubMed ID: 387873
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of immune globulin intravenous on opsonization of bacteria by classic and alternative complement pathways in premature serum.
    Shaio MF, Yang KD, Bohnsack JF, Hill HR.
    Pediatr Res; 1989 Jun 01; 25(6):634-40. PubMed ID: 2662129
    [Abstract] [Full Text] [Related]

  • 20. In vitro effect of intravenous immunoglobulin supplementation on serum opsonic activity in tracheostomised patients.
    Chandra RS, Dandekar UP, Karnard D, Tilve GH, Kshirsagar NA.
    Indian J Med Res; 1992 Apr 01; 96():109-11. PubMed ID: 1428049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.